Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-05-03

Clinical Trial Update: Topical Morphine for Analgesia in Patients With Skin Grafts [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating topical morphine for analgesia in skin graft patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical morphine (morphine)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Skin Transplantation, Pain | Phase 3 | Status: WITHDRAWN